This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1533317508320083v1 1533317508320083v2 23/5/417    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rosso, A. Articles by Mossey, J. Search for Related Content PubMed PubMed Citation Articles by Rosso, A. Articles by Mossey, J. Social Bookmarking                         What's this?

Caffeine: Neuroprotective Functions in Cognition and Alzheimers Disease

^* To whom correspondence should be addressed. E-mail: alr44{at}drexel.edu.

	Abstract

Alzheimer’s disease is a common problem in our elderly population. Although research is leading to improvements in our understanding of the underlying biology, we still have little understanding of the environmental risk factors associated with this disorder. Caffeine, an easily modifiable environmental factor, may have a protective effect on the likelihood of developing Alzheimer’s disease. This article reviews the association between caffeine from both a biologic and epidemiologic perspective. Further studies are needed to determine whether caffeine consumption could have a major affect on the development of Alzheimer’s disease or age-related cognitive decline.

First published on June 30, 2008, doi:10.1177/1533317508320083

American Journal of Alzheimer's Disease and Other Dementias® 2008;23:417.

A more recent version of this article appeared on October 1, 2008
This version was published on July 3, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?